Primary signet-ring cell/histiocytoid carcinoma of the eyelid expressing androgen receptors and treated with bicalutamide.
about
Primary signet-ring cell/histiocytoid carcinoma of the eyelid expressing androgen receptors and treated with bicalutamide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@en
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@nl
type
label
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@en
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@nl
prefLabel
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@en
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@nl
P2093
P356
P1476
Primary signet-ring cell/histi ...... and treated with bicalutamide.
@en
P2093
Fumihiko Tanioka
Hidekazu Fukamizu
Keiko Sakamoto
P2860
P304
P356
10.1111/1346-8138.13915
P577
2017-05-23T00:00:00Z